Cardiovascular and renal outcomes between sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors in patients with chronic kidney disease stages 4 and 5: a population-based study
Compared to DPP4i, SGLT2i did not show superiority in the reduction of cardiovascular or renal events in CKD stage 4-5 patients.
Authors
- Tien‐Hsing Chen (ORCID: https://orcid.org/0000-0001-6986-9765)
- Jhih-Wei Dai
- Ming‐Shyan Lin (ORCID: https://orcid.org/0000-0001-9348-8153)
- Te-Hsiung Wang
- Tien‐Shin Chou (ORCID: https://orcid.org/0000-0002-2185-7279)
- Tzu‐Hsien Tsai (ORCID: https://orcid.org/0000-0001-7066-6711)
- Chin-Ju Tseng
- Ming‐Lung Tsai (ORCID: https://orcid.org/0000-0002-4199-713X)
- Chien-Wei Cheng
- Yuan Lin
- Ming-Jui Hung
- Ning‐I Yang (ORCID: https://orcid.org/0000-0002-0721-1332)
Institutions
- Chang Gung University (TW)
- Taipei Municipal YangMing Hospital (TW)
- Keelung Chang Gung Memorial Hospital (TW)
- Chia-Yi Christian Hospital (TW)
- Chiayi Chang Gung Memorial Hospital (TW)
- Kitano Hospital (JP)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1016/j.diabres.2025.112205
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00